is jardiance a glp 1 agonist SGLT2 vs GLP-1 for CKD: Which Better? Jardiance® vs. Ozempic®: Similarities and
Description
This requires carefully designed clinical trials that account for commercial dynamics, as well as pre-launch disease education to prime market understanding regarding where new therapies fit in the treatment paradigm

All participants provided written informed consent before any trial-related activity

Diabetes Care 2019;42:S90-S102

13 Saxagliptin: Saxagliptin (Onglyza) was approved by the FDA in July 2009

[email protected] Purpose: The glucagon-like peptide-1 receptor (GLP-1R) is an effective therapeutic target for type 2 diabetes mellitus (T2DM) and non-alcoholic steatohepatitis (NASH)
Metabolic rebound after GLP-1 receptor agonist discontinuation: a systematic review and meta-analysis
